What CardioComm Solutions, Inc. does

CardioComm Solutions, Inc. is a Canadian public company listed on the TSX Venture Exchange (ticker: EKG) that develops and commercializes proprietary ECG software platforms for remote cardiac monitoring and arrhythmia analysis. Founded in 1989 and headquartered in Toronto with 1–10 employees, the company's product portfolio is anchored by two flagship platforms: GEMS FLEX, an ECG software platform for remote monitoring and cardiac analysis, and a 14-day Holter/LTCM platform that supports extended-wear and long-term continuous cardiac rhythm monitoring. Together these platforms target healthcare providers, cardiac care facilities, and remote patient monitoring use cases where extended cardiac assessment outside of clinical settings is required.

The company's revenue model is characterized as subscription/recurring for its ECG software platform, though specific pricing, contract terms, and customer counts are not publicly disclosed. CardioComm qualifies as a TSX-V reporting issuer with annual revenues under $10 million and is currently in a commercialization phase for its core products, funded in 2025 by a $512,000 insider loan facility from related parties (Xemxija Holdings, ITF Ventures, and CEO/director Etienne Grima) at 10% interest, secured against all company assets. The company has no disclosed institutional venture capital or private equity backing, and recent corporate actions — including debt settlement via share issuance to directors, stock option grants to the CEO, and a shift from quarterly to semi-annual financial reporting under Coordinated Blanket Order 51-933 — are consistent with a small, capital-constrained issuer.

Name

CardioComm Solutions, Inc.

Legal name

CardioComm Solutions, Inc.

Website

https://cardiocommsolutions.com

Company type

Public

Founded year

1989

Operating status

Operating

Headcount range

1–10 employees

Short description

CardioComm Solutions is a Canadian TSX-V-listed developer of proprietary ECG software platforms (GEMS FLEX and a 14-day Holter/LTCM platform) for remote cardiac monitoring and arrhythmia analysis, serving healthcare providers and remote patient monitoring use cases.

Ownership category

akta.pro rank

Product category

Cardiac Monitoring Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

akta.pro secondary industry

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• ECG software
• Cardiac monitoring
• Arrhythmia detection
• Holter monitoring
• Remote patient monitoring

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations

Revenue model

1. ECG Software Platform: Commercialization of proprietary ECG software platform for remote monitoring and ECG analysis products

Core offering

CardioComm Solutions develops and commercializes proprietary ECG (electrocardiogram) software platforms for remote cardiac monitoring and analysis. The company's flagship offerings—GEMS FLEX and the 14-Day Holter/LTCM Platform—enable healthcare providers to capture, transmit, and analyze cardiac rhythm data for arrhythmia detection, including extended-wear continuous monitoring of up to 14 days for patients both in clinical settings and remotely.

Product overview

CardioComm Solutions, Inc. is a healthcare technology company offering ECG software platforms for remote cardiac monitoring and ECG analysis. The company operates a platform-based architecture centered on two flagship products: GEMS FLEX and the 14-Day Holter/LTCM Platform. These software solutions work together to provide comprehensive ECG monitoring capabilities, enabling remote patient monitoring and cardiac arrhythmia detection for healthcare providers.

Differentiator

Problem solved

Functional benefit

Brands

• GEMS FLEX: ECG software platform being developed and commercialized by CardioComm Solutions
• 14-day Holter/LTCM Platform

Products and services

• GEMS FLEX ECG software platform designed for remote cardiac monitoring and ECG analysis, targeting healthcare providers and cardiac care facilities for arrhythmia detection and remote patient monitoring workflows.
• 14-Day Holter/LTCM Platform ECG software platform for extended-wear Holter and long-term continuous cardiac monitoring, enabling up to 14 days of continuous cardiac rhythm recording and analysis for healthcare providers and remote patient monitoring use cases.

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators4 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• AliveCor: AliveCor's KardiaMobile consumer/clinical ECG devices and cloud-based ECG analysis platform overlap with CardioComm's remote ECG monitoring and arrhythmia detection use cases, targeting both healthcare providers and remote/home-based patients.
• iRhythm Technologies: iRhythm's Zio long-term continuous monitoring patch and ECG analytics software directly competes with CardioComm's 14-Day Holter/LTCM platform in ambulatory cardiac arrhythmia detection, sharing the same end customers (healthcare providers, RPM programs) and recurring-revenue software model.

Emerging players

• Spacelabs Healthcare: Spacelabs provides Holter analysis software and ambulatory ECG monitoring systems used by cardiology practices, directly overlapping with CardioComm's core ECG analysis and arrhythmia detection workflow.
• HeartBeam: HeartBeam is a small public company developing credit-card-sized ECG devices and cloud-based cardiac arrhythmia detection software, making it a closely comparable micro-cap ECG software peer with similar scale and clinical focus.
• Biotricity: Biotricity is a small-cap cardiac monitoring company with remote patient monitoring and ECG solutions (Bioflux), making it a closely comparable micro-cap peer in business model, customer segment, and scale.

Broad incumbents

• GE HealthCare: GE HealthCare provides ECG carts, Holter analysis, and MUSE cardiology information systems that compete with CardioComm's ECG analysis and arrhythmia detection software in hospital and clinic settings.
• Preventice Solutions (Boston Scientific): Preventice's BodyGuardian remote cardiac monitoring suite competes with CardioComm's GEMS FLEX platform in ambulatory ECG and Holter monitoring; as part of Boston Scientific it benefits from substantially greater scale and channel reach.
• Hillrom / Baxter (Patient Monitoring): Baxter (via Hillrom/Welch Allyn) offers connected cardiac/ECG monitoring tools used by hospitals and clinicians; its cardiac diagnostics solutions overlap with CardioComm's provider-facing ECG software.
• Philips (Cardiac Monitoring): Philips offers a broad portfolio of cardiac monitoring, ECG, and telehealth solutions including its remote patient monitoring program, overlapping with CardioComm's ECG software platforms but at significantly larger scale and as part of a wider healthtech portfolio.
• Medtronic (Cardiac Diagnostics & Services): Medtronic's cardiac diagnostics portfolio, including insertable cardiac monitors and LINQ family, addresses the same underlying arrhythmia detection market as CardioComm, albeit with implantable rather than external ECG software.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CardioComm Solutions, Inc.